hit counter

Vyvanse For Depression: Lisdexamfetamine As An Adjunct Treatment

Vyvanse (Lisdexamfetamine) is a drug developed by Shire Pharmaceuticals as a successor to Adderall.¬† Vyvanse was first approved for the treatment of attention-deficit/hyperactivity disorder¬† (ADHD) in 2007.¬† In 2015, Vyvanse was approved for binge eating disorder and was found to successfully minimize appetite and number of binge eating episodes per week compared to a placebo. …

Read more